An optimized DHPLC protocol for molecular testing of the EXT1 and EXT2 genes in hereditary multiple osteochondromas
- 20 October 2005
- journal article
- research article
- Published by Wiley in Clinical Genetics
- Vol. 68 (6) , 542-547
- https://doi.org/10.1111/j.1399-0004.2005.00538.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode α1,4- N -acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesisProceedings of the National Academy of Sciences, 2001
- The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfateNature Genetics, 1998
- Identification of a Third EXT-like Gene (EXTL3) Belonging to the EXT Gene FamilyGenomics, 1998
- Identification and localization of the gene for EXTL, a third member of the multiple exostoses gene family.Genome Research, 1997
- Positional cloning of a gene involved in hereditary multiple exostosesHuman Molecular Genetics, 1996
- The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genesNature Genetics, 1996
- Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1)Nature Genetics, 1995
- The natural history of hereditary multiple exostoses.Journal of Bone and Joint Surgery, 1994
- Hereditary multiple exostoses.Journal of Medical Genetics, 1991
- HEREDITARY MULTIPLE EXOSTOSISThe Journal of Bone and Joint Surgery. British volume, 1963